TIMOTHY FENSKE
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN ANTONIO, TX NPI 1104877935
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX PFIZER INC. All categories
General Payments — all program years on this page
$685,852.57
- Category: General Payments
- Program years: PY2018–2024
- Record count: 610
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $48,434.40 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,435.00 | 7 |
| Consulting Fee | $16,175.00 | 9 |
| Food and Beverage | $1,963.63 | 23 |
| Travel and Lodging | $1,860.77 | 10 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $12,045.52 | 9 |
| BeiGene USA, Inc. | $9,145.94 | 4 |
| Incyte Corporation | $7,452.91 | 11 |
| ABBVIE INC. | $6,938.04 | 10 |
| Acerta Pharma LLC | $5,603.38 | 2 |
| Adaptive Biotechnologies Corporation | $3,295.23 | 3 |
| Ipsen Biopharmaceuticals, Inc | $2,835.25 | 3 |
| BeiGene, Ltd. | $435.00 | 1 |
| Genentech USA, Inc. | $294.47 | 2 |
| National Marrow Donor Program | $214.56 | 1 |
| Genmab U.S., Inc. | $174.10 | 3 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.